As part of the Almac Group, Galen and POA Pharma together contribute to a long-standing success story within the global pharmaceutical landscape. Simon Lawrence, Vice President of Marketing and Medical Nutrition, has been a key leader across both organisations for more than 35 years — shaping strategy, teams and patient‑focused solutions throughout the group.

Simon’s journey since joining Galen in 1986 reflects his unwavering dedication and passion for the pharmaceutical industry. This article explores the pivotal moments that have shaped his career, his current responsibilities, and his vision for the future as both Galen and POA continue to pursue ambitious growth grounded in shared values.

From Science to Sales: Building Strong Foundations

Simon’s career in pharmaceuticals began at Aston University in Birmingham, where he earned a degree in pharmacy. Initially inspired by the scientific side of the field, his interests soon evolved as he explored the behavioural factors influencing prescribing decisions. His academic projects on early adoption patterns for new medicines sparked a strong interest in the commercial aspects of healthcare.

After completing his pre‑registration year at Baxter Healthcare, Simon chose to build frontline experience in pharmaceutical sales. “I decided to start at the bottom to really understand what it was like at the coalface,” he explained. Working as a medical representative in the Birmingham and Coventry area gave him vital insight into the challenges facing sales professionals and the realities of customer engagement.

Climbing the Ladder: From Sales to Strategic Leadership

Simon joined Galen in 1986 as a medical representative, tasked with introducing the then lesser‑known brand to healthcare professionals. His commitment to relationship‑building and his close work with GPs and pharmacists drove tangible sales growth and helped establish trust in the organisation.

Over the following years, Simon progressed through regional and national sales management roles. This period played a defining role in shaping his leadership philosophy, grounded in nurturing talent and preparing the next generation of leaders. “A business is only as good as its people,” he often reflects — a belief that continues to shape his approach today.

In 1992, Simon transitioned into marketing and played a central role in building the company’s marketing function from the ground up. By developing strategies, training teams and fostering collaboration between marketing and sales, he helped cement strong commercial foundations.

Driving Innovation: Expanding Horizons

As the organisation grew, so too did Simon’s portfolio — spanning brand management, corporate marketing and business development. He was part of the multifunctional team behind the development and launch of Laxido, which became a major commercial success. His ability to collaborate across functions and navigate partnerships in international markets further underscored his strategic strengths.

In 2020, Simon relocated to Copenhagen to lead the integration of POA Pharma following its acquisition. During his four‑and‑a‑half years in the Nordics, he developed a clear growth strategy for the region and supported expansion into new markets such as Germany. Reflecting on this chapter, he shared: “Integrating a new business with a different culture while laying foundations for long‑term success was immensely rewarding.”

A Visionary Approach to Leadership

Returning to Craigavon in 2024, Simon brought a refreshed international perspective to his role as Vice President of Marketing and Medical Nutrition for the wider group. Before resuming the role, he invested six months in planning — defining key priorities and establishing a long‑term roadmap to align strategic marketing with future product launches.

He also focused on strengthening alignment across the medical nutrition division within both Galen and POA. By developing a more unified global strategy, Simon aims to enhance international collaboration and equip the business to deliver innovative solutions in an increasingly competitive market.

Fostering Growth: Developing People and Ideas

Mentorship has always been central to Simon’s leadership. “Nothing gives me greater pleasure than seeing individuals grow into leadership roles,” he shared. His commitment to succession planning ensures both organisations remain resilient and ready for the future.

Innovation is another core pillar of his leadership approach. Simon champions the integration of digital tools — from AI to analytics — into modern marketing practices. “Digital is as integral to the marketing mix as traditional methods,” he says, empowering teams to embrace a multi‑skilled and data‑driven approach.

Living the Ethos: Daring to Be Extraordinary

The shared ethos across Galen and POA — Dare to be extraordinary — resonates strongly with Simon’s leadership style. He believes extraordinary results stem from everyday actions, continuous improvement and recognising the collective effort behind every success. “When people feel valued and supported, they’re inspired to do extraordinary things,” he notes.

Simon takes great pride in the impact that products and solutions from both organisations have on patients’ lives, whether improving quality of life in oncology care or supporting individuals with inherited metabolic conditions. Throughout his career, he has remained committed to ensuring that passion, collaboration and compassion guide every decision.

Conclusion

Simon Lawrence’s journey — from his early sales career to his cross‑border leadership role supporting both Galen and POA Pharma — reflects an exceptional blend of strategic insight, people‑focused leadership and unwavering commitment to patient impact. His dedication to mentorship, innovation and values‑driven growth continues to shape the future of the Marketing & Medical Nutrition teams across both organisations.